These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16731710)

  • 41. [Discussion of vaccination policy useful?].
    van Logtestijn JG
    Tijdschr Diergeneeskd; 2002 Apr; 127(7):241; author reply 242. PubMed ID: 11962127
    [No Abstract]   [Full Text] [Related]  

  • 42. Foot-and-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact.
    Barasa M; Catley A; Machuchu D; Laqua H; Puot E; Tap Kot D; Ikiror D
    Transbound Emerg Dis; 2008 Oct; 55(8):339-51. PubMed ID: 18786073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triggers for foot and mouth disease vaccination in the United States.
    Parent KB; Miller GY; Hullinger PJ
    Rev Sci Tech; 2011 Dec; 30(3):789-96. PubMed ID: 22435191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preventive vaccination against foot and mouth disease not a realistic scenario?].
    Loonen WG
    Tijdschr Diergeneeskd; 2001 Dec; 126(23):765. PubMed ID: 11766538
    [No Abstract]   [Full Text] [Related]  

  • 46. Importance of foot and mouth disease vaccine purity in interpreting serological surveys.
    Smitsaart E; Espinoza AM; Maradei E; Cosentino B; Guinzburg M; Madonni G; Cadenazzi G; Bottini R; Filippi J; Bergmann I
    Rev Sci Tech; 2015 Dec; 34(3):755-66, 741-54. PubMed ID: 27044149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FMD vaccine first allowed to be made in U.S.
    Cima G
    J Am Vet Med Assoc; 2012 Aug; 241(3):298. PubMed ID: 22991743
    [No Abstract]   [Full Text] [Related]  

  • 48. [Vaccination against foot and mouth disease: current state and perspectives].
    Visser N; Thiel HJ
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent vaccination of goats with foot and mouth disease (FMD) and peste des petits ruminants (PPR) booster vaccines.
    Mansoor MK; Al-Rawahi AH; El-Tahir HA; Al-Faraei B; Hussain MH; Asi MN; Al-Hussani I; Sabar S
    Trop Anim Health Prod; 2018 Jan; 50(1):1-3. PubMed ID: 28940134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea.
    Kim AY; Tark D; Kim H; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Ko YJ
    J Vet Med Sci; 2017 Nov; 79(11):1822-1825. PubMed ID: 28943596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Foot-and-mouth disease: technical and political challenges to eradication.
    Smith MT; Bennett AM; Grubman MJ; Bundy BC
    Vaccine; 2014 Jun; 32(31):3902-8. PubMed ID: 24785105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
    Bergmann IE; Malirat V; Falczuk AJ
    Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Foot and mouth disease virus keeps lurking around the corner].
    Swormink BK
    Tijdschr Diergeneeskd; 2011 Jun; 136(6):396-9. PubMed ID: 21702179
    [No Abstract]   [Full Text] [Related]  

  • 57. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Research on foot-and-mouth disease vaccination of swine (trial of a trivalent O A C vaccine)].
    Giraud M; Berson JP; Loquerie R; Guerche J; Prunet P; Dhennin L; Dhennin L
    Bull Acad Vet Fr; 1970 Jul; 43(7):335-43. PubMed ID: 5534317
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparative study of immunity in swine vaccinated with foot-and-mouth disease vaccines prepared with various adjuvants].
    Mitev G; Tekerlekov P; Shopov I
    Vet Med Nauki; 1975; 12(1):16-22. PubMed ID: 1239851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
    Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.